{"transactions":[{"id":1637654,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94210,"kind":"person","name":"Binette Francois","position":1,"cik":"0001940686","reported_name":"Binette Francois","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Executive VP for R&D"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:44:03.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the option vested on October 18, 2023. The remainder of the option vests equally on October 18, 2024 and October 18, 2025."}],"balance_after":40000,"derivative":{"exercise_price":1.92,"expiration_date":"2032-10-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001731122-24-000268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000268/ownership.xml","form_type":"4"}},{"id":1637653,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94210,"kind":"person","name":"Binette Francois","position":1,"cik":"0001940686","reported_name":"Binette Francois","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Executive VP for R&D"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:44:03.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the option vested on October 18, 2023. The remainder of the option vests equally on October 18, 2024 and October 18, 2025."}],"balance_after":0,"derivative":{"exercise_price":2.15,"expiration_date":"2032-10-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001731122-24-000268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000268/ownership.xml","form_type":"4"}},{"id":1637652,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94210,"kind":"person","name":"Binette Francois","position":1,"cik":"0001940686","reported_name":"Binette Francois","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Executive VP for R&D"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:44:03.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":65000,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-13","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001731122-24-000268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000268/ownership.xml","form_type":"4"}},{"id":1637651,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94210,"kind":"person","name":"Binette Francois","position":1,"cik":"0001940686","reported_name":"Binette Francois","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Executive VP for R&D"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:44:03.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":0,"derivative":{"exercise_price":8.4,"exercise_date":"2023-04-18","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001731122-24-000268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000268/ownership.xml","form_type":"4"}},{"id":1637650,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94210,"kind":"person","name":"Binette Francois","position":1,"cik":"0001940686","reported_name":"Binette Francois","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Executive VP for R&D"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:44:03.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":65000,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-13","expiration_date":"2032-07-22","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001731122-24-000268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000268/ownership.xml","form_type":"4"}},{"id":1637649,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94210,"kind":"person","name":"Binette Francois","position":1,"cik":"0001940686","reported_name":"Binette Francois","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Executive VP for R&D"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:44:03.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"60% of the option vested on January 22, 2023 and 40% on July 22, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.38,"expiration_date":"2032-07-22","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001731122-24-000268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000268/ownership.xml","form_type":"4"}},{"id":2130867,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94210,"kind":"person","name":"Binette Francois","position":1,"cik":"0001940686","reported_name":"Binette Francois","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP for R&D"}}],"security":"Option to purchase shares of common stock","published_at":"2022-10-27T20:54:23.000Z","date":"2022-10-18","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests ratably over three years commencing on October 18, 2023."}],"balance_after":40000,"derivative":{"exercise_price":2.15,"expiration_date":"2032-10-18","underlying":"Common stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001731122-22-001812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112222001812/ownership.xml","form_type":"4"}}]}